07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
Q: I operate a hotel in New Jersey and heard New Jersey law now requires me to provide panic devices...
Read More >
Under the Americans with Disabilities Act (“ADA”), an employee is entitled to a reasonable accommo...
Read More >
The Federal Trade Commission has announced new HSR thresholds for 2021, which are lower than the exi...
Read More >
Dear YouDig? Guess what? There is a beautiful new ice arena at a major university in Ohio. We know...
Read More >
Big Tech as well as other global companies will likely have to modify their business models - Japa...
Read More >
The FTC, and antitrust enforcement in general, are having their moment. For example, in early Januar...
Read More >